Form 8-K - Current report:
SEC Accession No. 0001104659-23-030314
Filing Date
2023-03-09
Accepted
2023-03-09 07:02:11
Documents
15
Period of Report
2023-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm238560d2_8k.htm   iXBRL 8-K 25763
2 EXHIBIT 99.1 tm238560d2_ex99-1.htm EX-99.1 400010
6 GRAPHIC tm238560d2_ex99-1sp01img01.jpg GRAPHIC 4267
7 GRAPHIC image_001.gif GRAPHIC 43
  Complete submission text file 0001104659-23-030314.txt   635264

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA anip-20230309.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20230309_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20230309_pre.xml EX-101.PRE 22615
9 EXTRACTED XBRL INSTANCE DOCUMENT tm238560d2_8k_htm.xml XML 3464
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 23718139
SIC: 2834 Pharmaceutical Preparations